Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotagliflozin in Type 1 Diabetes and Diabetic Kidney Disease
NCT06217302Phase 3Recruiting
- Sponsor
- Alessandro Doria
- Start
- Oct 2024
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of sotagliflozin in diabetic kidney disease (DKD), sponsored by Alessandro Doria. Started Oct 2024; status: recruiting.
02
Drugs
sotagliflozin
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT06217302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06217302.